
Freenome
Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. The company's platform uses a proprietary algorithm method that aims to reinvent disease m...
Valuation
$0
Share Price
N/A
Total Raised
$1.4B
Last Round
N/A